Copyright Reports & Markets. All rights reserved.

Global Coronary Bioresorbable Scaffolds Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Coronary Bioresorbable Scaffolds Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Absorbable Magnesium Scaffolds
    • 1.3.3 Polymer Scaffold
    • 1.3.4 Polycarbonate Scaffold
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Coronary Bioresorbable Scaffolds Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Research and Development
    • 1.4.3 Hospital
    • 1.4.4 Others
  • 1.5 Global Coronary Bioresorbable Scaffolds Market Size & Forecast
    • 1.5.1 Global Coronary Bioresorbable Scaffolds Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Coronary Bioresorbable Scaffolds Sales Quantity (2021-2032)
    • 1.5.3 Global Coronary Bioresorbable Scaffolds Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Coronary Bioresorbable Scaffolds Product and Services
    • 2.1.4 Abbott Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Boston Scientific
    • 2.2.1 Boston Scientific Details
    • 2.2.2 Boston Scientific Major Business
    • 2.2.3 Boston Scientific Coronary Bioresorbable Scaffolds Product and Services
    • 2.2.4 Boston Scientific Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boston Scientific Recent Developments/Updates
  • 2.3 Medtronic
    • 2.3.1 Medtronic Details
    • 2.3.2 Medtronic Major Business
    • 2.3.3 Medtronic Coronary Bioresorbable Scaffolds Product and Services
    • 2.3.4 Medtronic Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Medtronic Recent Developments/Updates
  • 2.4 Elixir Medical
    • 2.4.1 Elixir Medical Details
    • 2.4.2 Elixir Medical Major Business
    • 2.4.3 Elixir Medical Coronary Bioresorbable Scaffolds Product and Services
    • 2.4.4 Elixir Medical Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Elixir Medical Recent Developments/Updates
  • 2.5 Biotronik
    • 2.5.1 Biotronik Details
    • 2.5.2 Biotronik Major Business
    • 2.5.3 Biotronik Coronary Bioresorbable Scaffolds Product and Services
    • 2.5.4 Biotronik Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Biotronik Recent Developments/Updates
  • 2.6 B. Braun
    • 2.6.1 B. Braun Details
    • 2.6.2 B. Braun Major Business
    • 2.6.3 B. Braun Coronary Bioresorbable Scaffolds Product and Services
    • 2.6.4 B. Braun Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 B. Braun Recent Developments/Updates
  • 2.7 MicroPort Scientific Corporation
    • 2.7.1 MicroPort Scientific Corporation Details
    • 2.7.2 MicroPort Scientific Corporation Major Business
    • 2.7.3 MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Product and Services
    • 2.7.4 MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 MicroPort Scientific Corporation Recent Developments/Updates
  • 2.8 Terumo Corporation
    • 2.8.1 Terumo Corporation Details
    • 2.8.2 Terumo Corporation Major Business
    • 2.8.3 Terumo Corporation Coronary Bioresorbable Scaffolds Product and Services
    • 2.8.4 Terumo Corporation Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Terumo Corporation Recent Developments/Updates
  • 2.9 Lepu Medical Technology (Beijing) Co., Ltd
    • 2.9.1 Lepu Medical Technology (Beijing) Co., Ltd Details
    • 2.9.2 Lepu Medical Technology (Beijing) Co., Ltd Major Business
    • 2.9.3 Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Product and Services
    • 2.9.4 Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Lepu Medical Technology (Beijing) Co., Ltd Recent Developments/Updates
  • 2.10 Hangzhou HuaAn Biotechnology Co., Ltd
    • 2.10.1 Hangzhou HuaAn Biotechnology Co., Ltd Details
    • 2.10.2 Hangzhou HuaAn Biotechnology Co., Ltd Major Business
    • 2.10.3 Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Product and Services
    • 2.10.4 Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Hangzhou HuaAn Biotechnology Co., Ltd Recent Developments/Updates
  • 2.11 LifeTech Scientific Corporation
    • 2.11.1 LifeTech Scientific Corporation Details
    • 2.11.2 LifeTech Scientific Corporation Major Business
    • 2.11.3 LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Product and Services
    • 2.11.4 LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 LifeTech Scientific Corporation Recent Developments/Updates

3 Competitive Environment: Coronary Bioresorbable Scaffolds by Manufacturer

  • 3.1 Global Coronary Bioresorbable Scaffolds Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Coronary Bioresorbable Scaffolds Revenue by Manufacturer (2021-2026)
  • 3.3 Global Coronary Bioresorbable Scaffolds Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Coronary Bioresorbable Scaffolds by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Coronary Bioresorbable Scaffolds Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Coronary Bioresorbable Scaffolds Manufacturer Market Share in 2025
  • 3.5 Coronary Bioresorbable Scaffolds Market: Overall Company Footprint Analysis
    • 3.5.1 Coronary Bioresorbable Scaffolds Market: Region Footprint
    • 3.5.2 Coronary Bioresorbable Scaffolds Market: Company Product Type Footprint
    • 3.5.3 Coronary Bioresorbable Scaffolds Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Coronary Bioresorbable Scaffolds Market Size by Region
    • 4.1.1 Global Coronary Bioresorbable Scaffolds Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Coronary Bioresorbable Scaffolds Consumption Value by Region (2021-2032)
    • 4.1.3 Global Coronary Bioresorbable Scaffolds Average Price by Region (2021-2032)
  • 4.2 North America Coronary Bioresorbable Scaffolds Consumption Value (2021-2032)
  • 4.3 Europe Coronary Bioresorbable Scaffolds Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Coronary Bioresorbable Scaffolds Consumption Value (2021-2032)
  • 4.5 South America Coronary Bioresorbable Scaffolds Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Coronary Bioresorbable Scaffolds Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Coronary Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 5.2 Global Coronary Bioresorbable Scaffolds Consumption Value by Type (2021-2032)
  • 5.3 Global Coronary Bioresorbable Scaffolds Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Coronary Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 6.2 Global Coronary Bioresorbable Scaffolds Consumption Value by Application (2021-2032)
  • 6.3 Global Coronary Bioresorbable Scaffolds Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Coronary Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 7.2 North America Coronary Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 7.3 North America Coronary Bioresorbable Scaffolds Market Size by Country
    • 7.3.1 North America Coronary Bioresorbable Scaffolds Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Coronary Bioresorbable Scaffolds Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Coronary Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 8.2 Europe Coronary Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 8.3 Europe Coronary Bioresorbable Scaffolds Market Size by Country
    • 8.3.1 Europe Coronary Bioresorbable Scaffolds Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Coronary Bioresorbable Scaffolds Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Coronary Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Coronary Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Coronary Bioresorbable Scaffolds Market Size by Region
    • 9.3.1 Asia-Pacific Coronary Bioresorbable Scaffolds Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Coronary Bioresorbable Scaffolds Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Coronary Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 10.2 South America Coronary Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 10.3 South America Coronary Bioresorbable Scaffolds Market Size by Country
    • 10.3.1 South America Coronary Bioresorbable Scaffolds Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Coronary Bioresorbable Scaffolds Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Coronary Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Coronary Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Coronary Bioresorbable Scaffolds Market Size by Country
    • 11.3.1 Middle East & Africa Coronary Bioresorbable Scaffolds Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Coronary Bioresorbable Scaffolds Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Coronary Bioresorbable Scaffolds Market Drivers
  • 12.2 Coronary Bioresorbable Scaffolds Market Restraints
  • 12.3 Coronary Bioresorbable Scaffolds Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Coronary Bioresorbable Scaffolds and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Coronary Bioresorbable Scaffolds
  • 13.3 Coronary Bioresorbable Scaffolds Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Coronary Bioresorbable Scaffolds Typical Distributors
  • 14.3 Coronary Bioresorbable Scaffolds Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Coronary Bioresorbable Scaffolds market size was valued at US$ 570 million in 2025 and is forecast to a readjusted size of US$ 1162 million by 2032 with a CAGR of 10.8% during review period.
    Coronary Bioresorbable Scaffolds is a new type of interventional device for coronary heart disease. It is made of biodegradable materials, which can provide temporary mechanical support and drug release to prevent vascular restenosis, and eventually completely degrade in the human body, leaving no permanent implants, so as to restore the natural function and structure of blood vessels.
    This report is a detailed and comprehensive analysis for global Coronary Bioresorbable Scaffolds market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Coronary Bioresorbable Scaffolds market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
    Global Coronary Bioresorbable Scaffolds market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
    Global Coronary Bioresorbable Scaffolds market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
    Global Coronary Bioresorbable Scaffolds market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Coronary Bioresorbable Scaffolds
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Coronary Bioresorbable Scaffolds market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, Medtronic, Elixir Medical, Biotronik, B. Braun, MicroPort Scientific Corporation, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Hangzhou HuaAn Biotechnology Co., Ltd, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Coronary Bioresorbable Scaffolds market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Absorbable Magnesium Scaffolds
    Polymer Scaffold
    Polycarbonate Scaffold
    Market segment by Application
    Research and Development
    Hospital
    Others
    Major players covered
    Abbott
    Boston Scientific
    Medtronic
    Elixir Medical
    Biotronik
    B. Braun
    MicroPort Scientific Corporation
    Terumo Corporation
    Lepu Medical Technology (Beijing) Co., Ltd
    Hangzhou HuaAn Biotechnology Co., Ltd
    LifeTech Scientific Corporation
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Coronary Bioresorbable Scaffolds product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Coronary Bioresorbable Scaffolds, with price, sales quantity, revenue, and global market share of Coronary Bioresorbable Scaffolds from 2021 to 2026.
    Chapter 3, the Coronary Bioresorbable Scaffolds competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Coronary Bioresorbable Scaffolds breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Coronary Bioresorbable Scaffolds market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Coronary Bioresorbable Scaffolds.
    Chapter 14 and 15, to describe Coronary Bioresorbable Scaffolds sales channel, distributors, customers, research findings and conclusion.

    Buy now